DUBLIN, April. 11, 2014 /PRNewswire/ --
Research and Markets
) has announced the addition of the
report to their offering.
This report categorizes the market into the peripheral nerve repair segment and the neuromodulation segment. The peripheral nerve repair segment consists of direct nerve repair, nerve grafting, and stem cell therapy, while neuromodulation is divided into external and internal neuromodulation segments. The market is expected to grow at a strong CAGR during the study period. This is due to factors such as the rise in aging population (with multiple co-occurring disorders such as Alzheimer's, Parkinson's, chronic pain, and epilepsy), increasing incidence of peripheral nerve injuries, favorable reimbursement policies, and technological advancements.
The market is estimated based on surgery volume and products revenue. Based on surgeries, the market is classified into neuromodulation, direct nerve repair, nerve grafting, and stem cell therapy. Direct nerve repair is categorized into three types, namely, epineural, perineural, and group fascicular repair and nerve grafting is performed by using autografts, allografts, and xenografts. Neuromodulation is classified into internal stimulation and external stimulation. Internal stimulation is a minimally invasive technique which is further classified into spinal cord stimulation, deep brain stimulation, sacral nerve stimulation, vagus nerve stimulation, and gastric electrical stimulation. External stimulation is classified into transcutaneous electrical nerve stimulation and transcranial magnetic stimulation.
Based on products, the market is categorized into two segments, namely, biomaterials and neuromodulation. The biomaterials market is further segmented into nerve conduits, nerve wraps, nerve protectors, and nerve connectors. The market is driven by improved efficacy, enhanced functional recovery, and rising awareness among neurological surgeons towards biomaterials. Neuromodulation products include Deep Brain Stimulators, Spinal Cord Stimulators, Sacral Nerve Stimulators, Vagus Nerve Stimulators, and Gastric Electric Stimulators.
Neuromodulation in this market is expected to grow at the highest CAGR in the next five years. The large number of effective products (with expanded applications) from major players and about 25
products entering into clinical trials in the next two years are the major factors driving this market. Though the peripheral market is in its infant stage, it proves to be promising due to the technological advancements in nerve grafting, rising awareness in the patient population, and quick recovery.
North America is the dominant market, with around one-third of the share. The leading market share is due to the high prevalence of chronic disorders like epilepsy, Parkinson's, Alzheimer's, chronic pain, urine and fecal incontinence, and depression, along with rise in aging population and large number of U.S. based manufacturers.Key players in the neuromodulation segment in this region include Medtronic (U.S.), St. Jude Medical(U.S.), Boston Scientific Corporation(U.S.), and Cyberonics(U.S.), while the leading players in the peripheral nerve repair market include Integra LifeSciences Corporation(U.S.), Stryker Corporation(U.S.), and AxoGen, Inc.(U.S.).
Key Topics Covered:
2 Executive Summary
3 Market Overview
4 Global Nerve Repair And Regeneration Market
5 Geographic Analysis
6 Competitive Landscape
7 Company Profiles (Overview, Financials, Products & Services, Strategy, & Developments)*
- Alafair Biosciences, Inc
- Axogen, Inc
- Baxter International, Inc
- Biocontrol Medical
- Boston Scientific Corporation
- Cyberonics, Inc
- Integra Lifesciences Holdings Corp
- Medtronic, Inc
- Orthomed SAS
- St Jude Medical
- Stryker Corporation
For more information visit http://www.researchandmarkets.com/research/kjxvb2/nerve_repair_and
Laura Wood , +353-1-481-1716, [email protected]
SOURCE Research and Markets